← Leaderboards
Peter Teuber
Orphan Therapeutics, Llc
$560,385
Attributed
$560,385
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $286.8K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
FDA$560,385 · 1
By mechanism
R01$560,385 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trial Phase Iii”
- Lawrence Corey · Fred Hutchinson Cancer Center$186,046,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$175,092,839
- Judith S. Currier · University Of California Los Angeles$170,828,011
- Philip J Disaia · University Of California Irvine$168,935,332
- Peter B. Gilbert · Fred Hutchinson Cancer Center$146,817,805
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$129,608,255
Research focus
Clinical Trial Phase IiiDrug Screening /Evaluation